Danny N. Legge
University Walk
Bristol, ENG, United Kingdom
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Multi-tissue expression and splicing data prioritise anatomical subsite- and sex-specific colorectal cancer susceptibility genes.
Journal: Nature communications
Published: September 05, 2024
Spliceosomal vulnerability of MYCN-amplified neuroblastoma is contingent on PRMT5-mediated regulation of epitranscriptomic and metabolomic pathways.
Journal: Cancer letters
Published: June 12, 2024
Identifying targetable metabolic dependencies across colorectal cancer progression.
Journal: Molecular metabolism
Published: April 17, 2024
Identifying metabolic features of colorectal cancer liability using Mendelian randomization.
Journal: eLife
Published: December 21, 2023
Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes.
Journal: EBioMedicine
Published: July 19, 2023
Identifying metabolic features of colorectal cancer liability using Mendelian randomization.
Journal: medRxiv : the preprint server for health sciences
Published: March 22, 2023
In-silico and in-vitro morphometric analysis of intestinal organoids.
Journal: PLoS computational biology
Published: February 06, 2023
Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer.
Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer.
Journal: Exploration of targeted anti-tumor therapy
Published: January 19, 2023
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition.
Journal: Cancer & metabolism
Published: November 21, 2022
The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor.
Journal: Molecular oncology
Published: June 07, 2021
Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study.
Journal: PLoS genetics
Published: October 13, 2020
Last Updated: 09/26/2026